Evidence map›Paper›PMID 37076826›Full record

ArticleBMC medical genomics2023

Heterozygous variant in FGFR3 underlying severe phenotypes in the second trimester: a case report.

Shujun Chen, Hongmei Dong, Yong Luo, Yingpin Zhang, Pan Li

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shujun ChenDepartment of Ultrasound, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, 400010, China.
Hongmei DongDepartment of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Yong LuoDepartment of Ultrasound, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, 400010, China.
Yingpin ZhangDepartment of Ultrasound, The First People's Hospital of Chongqing Liang Jiang New Area, Chongqing, 400010, China.
Pan LiDepartment of Ultrasound, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China. lipan@hospital.cqmu.edu.cn.
Dalian Medical University · CNFirst People's Hospital of Chongqing · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAchondroplasia is a congenital skeletal system malformation caused by missense variant of FGFR3 gene with an incidence of 1 per 20,000-30,000 newborns, which is an autosomal dominant inheritance disease. Despite similar imaging features, the homozygous achondroplasia is absolutely lethal due to thoracic stenosis, whereas heterozygous achondroplasia does not lead to fetal death. CASE PRESENTATION: A fetus with progressive rhizomelic short limbs and overt narrow chest was detected by prenatal ultrasound in the second trimester. Gene sequencing results of amniotic fluid sample indicated a rare missense variant NM_000142.4: c.1123G > T(p.Gly375Cys), leading to a glycine to cysteine substitution. Re-sequencing confirmed that it was a heterozygous variant, and thoracic stenosis was then confirmed in the corpse by radiological examination.

conclusionsWe identified a heterozygous variant of the FGFR3 gene as the rare pathogenic variant of severe achondroplasia in a fetus. Heterozygous variants of p.Gly375Cys may have a severe phenotype similar to homozygote. It's crucial to combine prenatal ultrasound with genetic examination to differentiate heterozygous from homozygous achondroplasia. The p.Gly375Cys variant of FGFR3 gene may serve as a vital target for the diagnosis of severe achondroplasia.

Indexed as

AchondroplasiaConstriction, PathologicFemaleGenetic TestingHumansMutationPhenotypePregnancyReceptor, Fibroblast Growth Factor, Type 3FGFR3 protein, humanReceptor, Fibroblast Growth Factor, Type 3AchondroplasiaFGFR3 geneHeterozygousRare variantSevere phenotype

Identifiers

PMID37076826
PMCPMC10116793
OpenAlexW4366403967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.